News

Published on 6 Mar 2023 on Insider Monkey via Yahoo Finance

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call Transcript

Article preview image

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call Transcript March 3, 2023

Operator: Good afternoon, and welcome to the Lexicon Pharmaceuticals Fourth Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. I would now like to turn the conference over to Carrie Siragusa. Please go ahead.

Read the rest of the article
NASDAQ.LXRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin

Lexicon Pharmaceuticals, Inc. LXRX announced data from a new post hoc analysis of its phase III i...

Zacks via Yahoo Finance 13 Mar 2024
ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday’s...

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points o...

Benzinga 12 Mar 2024
Lexicon reports positive sotagliflozin trial results

Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX ) has revealed findings from a post hoc analysis of ...

Investing.com 12 Mar 2024
Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump By Benzinga

Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump

Investing.com 12 Mar 2024
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday’s Mid-Day...

Shares of Mesoblast Limited MESO rose sharply during Monday’s session after the company announce...

Benzinga 11 Mar 2024
Lexicon Pharmaceuticals secures $250 million in private financing

Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX ) announced today it has entered into a securities...

Investing.com 11 Mar 2024
Lexicon Pharmaceuticals secures $250 million in private financing

Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX ) announced today it has entered into a securities...

Investing.com 11 Mar 2024
Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) largest shareholders are private equity firms with 48%...

Key Insights Lexicon Pharmaceuticals' significant private equity firms ownership suggests that th...

Simply Wall St. via Yahoo Finance 14 Jan 2024
Director Philippe Amouyal's Strategic 200,000 Share Purchase in Lexicon Pharmaceuticals Inc

Recent insider trading activity has caught the attention of market analysts and investors alike, ...

GuruFocus.com via Yahoo Finance 15 Nov 2023
Insiders Buying Blend Labs And 3 Other Stocks Under $2 - ESS Tech (NYSE:GWH), Blend Labs (NYSE:BLND)

The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, i...

Benzinga 14 Nov 2023

Copyright Statfolio @ 2024

Social Accounts